+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Antithrombotic Drugs Market 2024-2028

  • PDF Icon

    Report

  • 161 Pages
  • July 2024
  • Region: Global
  • TechNavio
  • ID: 5835924
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antithrombotic drugs market is forecasted to grow by USD 21.78 billion during 2023-2028, accelerating at a CAGR of 7.68% during the forecast period. The report on the antithrombotic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of coagulation disorders, introduction of novel oral anticoagulants, and strong R&D pipeline in building.

The antithrombotic drugs market is segmented as below:

By Route Of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advent of anticoagulant antidotes as one of the prime reasons driving the antithrombotic drugs market growth during the next few years. Also, strategic partnerships and acquisitions of companies in market focus and growing new developments in market focus will lead to sizable demand in the market.

The report on the antithrombotic drugs market covers the following areas:

  • Antithrombotic drugs market sizing
  • Antithrombotic drugs market forecast
  • Antithrombotic drugs market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antithrombotic drugs market vendors that include AbbVie Inc., Aspen Pharmacare Holdings Ltd., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the antithrombotic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Antithrombotic Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Antithrombotic Drugs Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Injectable - Market size and forecast 2023-2028
Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Chart on Injectable - Year-over-year growth 2023-2028 (%)
Data Table on Injectable - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2023-2028
Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacy - Market size and forecast 2023-2028
Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacy - Market size and forecast 2023-2028
Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Aspen Pharmacare Holdings Ltd.
Aspen Pharmacare Holdings Ltd. - Overview
Aspen Pharmacare Holdings Ltd. - Business segments
Aspen Pharmacare Holdings Ltd. - Key offerings
Aspen Pharmacare Holdings Ltd. - Segment focus
12.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.8 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.11 Fresenius Kabi AG
Fresenius Kabi AG - Overview
Fresenius Kabi AG - Business segments
Fresenius Kabi AG - Key offerings
Fresenius Kabi AG - Segment focus
12.12 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd. - Overview
Otsuka Pharmaceutical Co. Ltd. - Product / Service
Otsuka Pharmaceutical Co. Ltd. - Key offerings
12.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Antithrombotic Drugs Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 33: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Route of Administration
Exhibits 35: Data Table on Comparison by Route of Administration
Exhibits 36: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by Route of Administration ($ million)
Exhibits 45: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Distribution Channel
Exhibits 49: Data Table on Comparison by Distribution Channel
Exhibits 50: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits 62: Market opportunity by Distribution Channel ($ million)
Exhibits 63: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 67: Chart on Geographic comparison
Exhibits 68: Data Table on Geographic comparison
Exhibits 69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 105: Market opportunity By Geographical Landscape ($ million)
Exhibits 106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 107: Impact of drivers and challenges in 2023 and 2028
Exhibits 108: Overview on criticality of inputs and factors of differentiation
Exhibits 109: Overview on factors of disruption
Exhibits 110: Impact of key risks on business
Exhibits 111: Companies covered
Exhibits 112: Matrix on companies position and classification
Exhibits 113: Aspen Pharmacare Holdings Ltd. - Overview
Exhibits 114: Aspen Pharmacare Holdings Ltd. - Business segments
Exhibits 115: Aspen Pharmacare Holdings Ltd. - Key offerings
Exhibits 116: Aspen Pharmacare Holdings Ltd. - Segment focus
Exhibits 117: AstraZeneca Plc - Overview
Exhibits 118: AstraZeneca Plc - Product / Service
Exhibits 119: AstraZeneca Plc - Key news
Exhibits 120: AstraZeneca Plc - Key offerings
Exhibits 121: Bayer AG - Overview
Exhibits 122: Bayer AG - Business segments
Exhibits 123: Bayer AG - Key news
Exhibits 124: Bayer AG - Key offerings
Exhibits 125: Bayer AG - Segment focus
Exhibits 126: Boehringer Ingelheim International GmbH - Overview
Exhibits 127: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 128: Boehringer Ingelheim International GmbH - Key news
Exhibits 129: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 130: Bristol Myers Squibb Co. - Overview
Exhibits 131: Bristol Myers Squibb Co. - Product / Service
Exhibits 132: Bristol Myers Squibb Co. - Key news
Exhibits 133: Bristol Myers Squibb Co. - Key offerings
Exhibits 134: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 135: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits 136: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 137: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 138: Eli Lilly and Co. - Overview
Exhibits 139: Eli Lilly and Co. - Product / Service
Exhibits 140: Eli Lilly and Co. - Key news
Exhibits 141: Eli Lilly and Co. - Key offerings
Exhibits 142: F. Hoffmann La Roche Ltd. - Overview
Exhibits 143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 144: F. Hoffmann La Roche Ltd. - Key news
Exhibits 145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 147: Fresenius Kabi AG - Overview
Exhibits 148: Fresenius Kabi AG - Business segments
Exhibits 149: Fresenius Kabi AG - Key offerings
Exhibits 150: Fresenius Kabi AG - Segment focus
Exhibits 151: Hikma Pharmaceuticals Plc - Overview
Exhibits 152: Hikma Pharmaceuticals Plc - Business segments
Exhibits 153: Hikma Pharmaceuticals Plc - Key news
Exhibits 154: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 155: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 156: Novartis AG - Overview
Exhibits 157: Novartis AG - Business segments
Exhibits 158: Novartis AG - Key news
Exhibits 159: Novartis AG - Key offerings
Exhibits 160: Novartis AG - Segment focus
Exhibits 161: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibits 162: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibits 163: Otsuka Pharmaceutical Co. Ltd. - Key offerings
Exhibits 164: Sanofi SA - Overview
Exhibits 165: Sanofi SA - Business segments
Exhibits 166: Sanofi SA - Key news
Exhibits 167: Sanofi SA - Key offerings
Exhibits 168: Sanofi SA - Segment focus
Exhibits 169: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 170: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 171: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 172: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 173: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 174: Viatris Inc. - Overview
Exhibits 175: Viatris Inc. - Business segments
Exhibits 176: Viatris Inc. - Key news
Exhibits 177: Viatris Inc. - Key offerings
Exhibits 178: Viatris Inc. - Segment focus
Exhibits 179: Inclusions checklist
Exhibits 180: Exclusions checklist
Exhibits 181: Currency conversion rates for US$
Exhibits 182: Research methodology
Exhibits 183: Information sources
Exhibits 184: Data validation
Exhibits 185: Validation techniques employed for market sizing
Exhibits 186: Data synthesis
Exhibits 187: 360 degree market analysis
Exhibits 188: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global antithrombotic drugs market: AbbVie Inc., Aspen Pharmacare Holdings Ltd., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advent of anticoagulant antidotes."

According to the report, one of the major drivers for this market is the growing prevalence of coagulation disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Aspen Pharmacare Holdings Ltd.
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Fresenius Kabi AG
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.